J. Goldman & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
3,551
-6,325
| -64% | -$1.91M | 0.03% | 244 |
|
|
2025
Q1 | $3.27M | Buy |
+9,876
| New | +$3.27M | 0.08% | 165 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 309 |
|
|
2023
Q2 | – | Sell |
-11,971
| Closed | -$2.9M | – | 322 |
|
|
2023
Q1 | $2.9M | Buy |
+11,971
| New | +$2.9M | 0.12% | 134 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 323 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 325 |
|
|
2018
Q2 | – | Sell |
-4,528
| Closed | -$529K | – | 287 |
|
|
2018
Q1 | $529K | Buy |
+4,528
| New | +$529K | 0.02% | 183 |
|
|
2013
Q3 | – | Sell |
-2,857
| Closed | -$499K | – | 198 |
|
|
2013
Q2 | $499K | Buy |
+2,857
| New | +$499K | 0.05% | 137 |
|